At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
experimental protocol treatment "The New Authority"behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In the news
2 articles- Sanofi wins type 1 diabetes nod for Tzield after requesting to revoke CNPVBioSpace FDA·2026-06-15
- #ADA26: Roche incretin shot works in mid-stage trial in type 1 diabetesEndpoints News·2026-06-05
Matched to this trial by ClinicalIndexfrom reputable biotech & medical press.
Development and Assessment of a Treatment Protocol for Poorly Controlled Diabetic (Type 1) Adolescents, Based on "The New Authority" Model
In Brief
A clinical study evaluating experimental protocol treatment "The New Authority" for Type 1 Diabetes. Completed, enrolled 40 participants across 1 site.
Detailed Summary
It is presumed that families of poorly controlled diabetic adolescents (type 1) would benefit from parents' counselling, guided by "the New Authority" model.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesIsrael
CollaboratorsJuvenile Diabetes Research Foundation
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartJul 2014
Primary CompletionMar 2018
TodayJul 2026
First PostedMar 21, 2014
Enrollment StartJul 30, 2014
Primary CompletionMar 30, 2018
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 12.3 years ago
Interventions
experimental protocol treatment "The New Authority"behavioral